Form 4: Hudson Susan Claire reports multiple insider transactions in FLS
Rhea-AI Filing Summary
Hudson Susan Claire reported multiple insider transaction types in a Form 4 filing for FLS. The filing lists transactions totaling 64,369 shares at a weighted average price of $87.02 per share. Following the reported transactions, holdings were 13,853 shares.
Positive
- None.
Negative
- None.
Insights
Routine equity awards and tax-withholding trades reported for Flowserve’s CLO.
Flowserve’s Chief Legal Officer received new grants of 7,287 performance rights and 7,287 restricted stock units, both with three-year performance or service vesting. These instruments align compensation with metrics like ROIC, earnings per share growth, free cash flow, and relative total shareholder return.
A separate transaction on February 13, 2026 shows 21,242 common shares acquired at $0, likely from vesting or conversion, and 8,425 shares disposed under code F to cover tax obligations at $87.02 per share. Such tax-withholding dispositions are non-open-market and generally viewed as administrative rather than directional trades.
Following these entries, the officer directly holds 19,406 common shares, plus sizeable performance rights and RSU balances. These filings primarily clarify the structure and scale of management’s incentive alignment; they do not, by themselves, signal a change in corporate outlook.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Rights | 20,128 | $0.00 | -- |
| Grant/Award | Common Stock | 21,242 | $0.00 | -- |
| Tax Withholding | Common Stock | 8,425 | $87.02 | $733K |
| Grant/Award | Performance Rights | 7,287 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 7,287 | $0.00 | -- |
Footnotes (1)
- Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2023 and ending on December 31, 2025 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income for each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
